PhD position in PET imaging of beta cells in diabetes
Sort on published: 2019-04-23
Uppsala University is a comprehensive research-intensive university with a strong international standing. Our mission is to pursue top-quality research and education and to interact constructively with society. Our most important assets are all the individuals whose curiosity and dedication make Uppsala University one of Sweden’s most exciting workplaces. Uppsala University has 44.000 students, 7.100 employees and a turnover of SEK 7 billion.
The research group Theranostics is located by the Rudbeck Laboratory, and close to the Biomedical Center (BMC) and the Uppsala University Hospital. Olof Eriksson’s lab is associated with Science for Life Laboratory and focuses on development of molecular imaging methodologies for improved diagnosis, management and treatment of metabolic disease and cancer (https://www.ilk.uu.se/research-groups/theranostics_en/eriksson-lab). The research group is a part of the Department of Medicinal Chemistry.
Project description/ duties:
The aim of the project is to develop and evaluate PET radiopharmaceuticals for in vivo molecular imaging of beta cell mass, for applications in metabolic disease, including diabetes. We recently discovered several novel receptors, e.g. GPR44 and DGCR2, expressed in pancreatic beta cells which constitute promising imaging targets, as well as potential therapeutic targets. The PhD student will be responsible for the in vitro and in vivo biological evaluation of PET radiopharmaceuticals (i.e. small molecules or peptides radiolabeled with Fluorine-18 or Gallium-68), and work closely with a team of radiochemists and biologists.
The radiopharmaceutical development includes in vitro evaluation in tissues and cell-lines, and in vivo evaluation in disease models of diabetes. Apart from research, the PhD student may participate in teaching and routine maintenance of the lab.
We are looking for a highly motivated student for a PhD position. We welcome applications from candidates that already have, or who expect to soon have, a Master of Science degree in biomedicine, engineering, natural sciences, pharmacy, medicine, chemistry or similar.
Experience of laboratory evaluation of radiopharmaceuticals including in vitro assays (cells/ autoradiography) and in vivo assays (biodistribution, PET/SPECT/CT/MRI imaging, image analysis) is an advantage. Completed courses in laboratory animal science (e.g. FELASA C) or radiation protection are an advantage. The applicant must be fluent in English with excellent communication skills.
A person meets the general admission requirements for third-cycle courses and study programmes if he or she:
- has been awarded a second-cycle qualification, or
- has satisfied the requirements for courses comprising at least 240 credits of which at least 60 credits were awarded in the second cycle, or
- has acquired substantially equivalent knowledge in some other way in Sweden or abroad.
The application should be written in English and contain a cover letter describing the applicant’s research interests, an updated CV including a list of previous publications (if any), as well as copies of diplomas and certificates of higher academic degrees. Also include information about previous experience of research and why you would like to be enrolled as a PhD student. Please also attach contact details (name, e-mail, phone number) to at least two referees and/or letters of recommendation.
Selection of candidates is based on qualifications, previous work and/or research experience within the field, and personal suitability. Shortlisted candidates will be called for interviews as soon as possible after the application deadline. The enrolment will then be approved by the Medicine and Pharmacy disciplinary domain at Uppsala University.
Rules governing PhD candidates are set out in the Higher Education Ordinance Chapter 5, §§ 1-7 and in Uppsala university's rules and guidelines.
Information about education at the postgraduate level, admission requirements and admission decisions can be found at http://www2.medfarm.uu.se/utbildning/forskarniva/vill_du_borja/
Uppsala University strives to be an inclusive workplace that promotes equal opportunities and attracts qualified candidates who can contribute to the University’s excellence and diversity. We welcome applications from all sections of the community and from people of all backgrounds.
Salary: According to local agreement for PhD students and teaching assistants.
Starting date: 2019-08-01 or as soon as possible thereafter.
Position: The graduate program covers four years of full-time study. The position can be combined with teaching or other duties at the department (maximum 20%), which prolongs the employment with the corresponding time.
Type of Position: 100 %.
For further information about the position please contact: Associate Senior Lecturer Olof Eriksson (firstname.lastname@example.org).
For further information about the employment please contact: Head of Department Anders Karlén (email@example.com).
Please submit your application by 31 May 2019, UFV-PA 2019/1400.
Please do not send offers of recruitment or advertising services. Applications must be submitted as described in this advertisement.
Placement: Department of Medicinal Chemistry
Type of employment: Full time , Temporary position longer than 6 months
Pay: Fixed salary
Number of positions: 1
Working hours: 100 %
County: Uppsala län
Number of reference: UFV-PA 2019/1400
Last application date: 2019-05-31
As an employee at Uppsala University, you receive a number of great benefits. Here we have listed the most important ones.
HR Excellence in Research
The HR Excellence in Research logo is a seal of quality that lets you know Uppsala University is committed to implementing the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers.